Decarboxylase domain containing protein, also known as DCAKD or CARKD, is a protein encoded by the DCAKD gene in humans. This protein belongs to the carbohydrate kinase family and contains a conserved ATPase domain. However, unlike many other members of this family, it doesn't have a clear substrate and its specific biological function remains largely unknown.The DCAKD gene is expressed in various tissues, with higher levels observed in the kidney and brain, suggesting its role in the normal physiological functions of these organs. However, the exact processes that DCAKD is involved in are yet to be elucidated.
Interestingly, genetic studies have linked variations in the DCAKD gene to several human conditions. For instance, certain variants of this gene have been associated with type 2 diabetes and metabolic syndrome, suggesting a role in glucose metabolism or insulin signaling. However, further research is needed to clarify these associations and to understand the possible mechanistic pathways involved.In summary, DCAKD is a carbohydrate kinase family protein whose exact biological function remains unclear. Despite its elusive role, genetic studies have associated DCAKD with metabolic and kidney diseases, indicating its importance in these pathways.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
Can influence gene expression and may indirectly affect DCAKD expression through transcriptional regulation. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $42.00 $72.00 $124.00 $238.00 $520.00 $1234.00 | 11 | |
A polyphenol that can modulate various signaling pathways, potentially influencing DCAKD activity or expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
A DNA methyltransferase inhibitor, can alter gene expression patterns, possibly impacting DCAKD. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $149.00 $470.00 $620.00 $1199.00 $2090.00 | 33 | |
A histone deacetylase inhibitor, could impact gene expression and indirectly influence DCAKD. | ||||||
Curcumin | 458-37-7 | sc-200509 sc-200509A sc-200509B sc-200509C sc-200509D sc-200509F sc-200509E | 1 g 5 g 25 g 100 g 250 g 1 kg 2.5 kg | $36.00 $68.00 $107.00 $214.00 $234.00 $862.00 $1968.00 | 47 | |
Known for its effect on transcription factors and signaling pathways, potentially influencing DCAKD. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $60.00 $185.00 $365.00 | 64 | |
Affects gene expression and has been shown to interact with various transcription factors, possibly affecting DCAKD. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $30.00 $46.00 $82.00 $218.00 | 19 | |
A histone deacetylase inhibitor, potentially impacting DCAKD expression by altering chromatin structure. | ||||||
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $76.00 $150.00 $725.00 $1385.00 $2050.00 | 73 | |
Activates adenylate cyclase, potentially impacting DCAKD expression through cAMP-dependent pathways. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Influences Wnt signaling and glycogen synthase kinase 3 (GSK-3) activity, potentially affecting DCAKD. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
A proteasome inhibitor, could indirectly affect DCAKD by influencing protein degradation pathways. | ||||||